Melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: Review of transplant-related mortality

Leukemia and Lymphoma

Volumn 25, Issue 5-6, 1997, Pages 565-572

  Hjiyiannakis, P ^a   Mehta, J ^a   Milan, S ^a   Powles, R ^a   Hinson, J ^a   Tait, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Acute leukemia; Allogeneic bone marrow transplantation; Interstitial pneumonitis; Melphalan; Regimen related toxicity; Total body irradiation

Indexed keywords

CYCLOSPORIN; MELPHALAN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CANCER MORTALITY; CANCER REGRESSION; CAUSE OF DEATH; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SEPSIS; WHOLE BODY RADIATION;

EID: 0030739810     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709039045     Document Type: Article

References (25)

1. Thomas, E., Storb, R., Clift, R. A., et al. (1975). Bone-marrow transplantation, N. Engl. J. Med., 292, 832-843 and 895-902.
2. Powles, R. L., Clink, H. M., Spence, D. et al. (1980). Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet, 1, 327-329.
3. Powles, R. L., Morgenstern, G., Clink, H. M. et al. (1980). The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet, 1, 1047-1050
4. Lin, H. S. and Drzymala, R. E. (1992). Total body and hemibody irradiation. In: Perez, A., Brady, L. W., eds. Principles and Practice of Radiation Oncology, 2nd ed London, Lippincott, 1992, pp 256-263.
5. Clift, R. A., Buckner, C. D., Appelbaum, F. R. et al. (1990). Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood, 76, 1867-1871.
6. Clift, R. A., Buckner, C. D., Appelbaum, F. R. et al. (1991). Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood, 77, 1660-1665.
7. Petersen, F. B., Deeg, H. J., Buckner, C. D. et al. (1992). Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide - a phase I trial. Int. J. Radiat. Oncol Biol. Phys., 23, 1027-1032.
8. Bearman, S I., Appelbaum, F. R., Buckner, C. D. et al. (1988). Regimen-related toxicity in patients undergoing bone marrow transplantation. J. Clin. Oncol., 6, 1562-1568.
9. Deeg, H. J. (1990). Delayed complications and long-term effects after bone marrow transplantation, Hematol. Oncol. Clin. North Am., 4, 641-657.
10. Helenglass, G., Powles, R. L., McElwain, T. J. et al. (1988). Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission, Bone Marrow Transplant., 3, 21-29.
11. Ball, G. A. (1988). Total body irradiation: a specialised unit, Radiograph; 54, 104-108.
12. Fife, K., Milan, S., Westbrook, K., Powles, R. and Tait, D. (1994) Risk factors for requiring cataract surgery following total body irradiation. Radiother. Oncol., 33, 93-98
13. Powles, R. L., Morgenstern, G. R., Kay, H. E. et al. (1983). Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet, 1, 612-615.
14. Mehta, J., Powles, R., Horton, C., Milan, S., Singhal, S. and Treleaven, J (1995). The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant, 15, 853-858.
15. Singhal, S., Mehta, J., Powles, R. et al. (1995). Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation. Bone Marrow Transplant., 15, 777-781.
16. Powles, R., Milan, S., Horton, C., Singhal, S., Treleaven, J. and Mehta, J. (1996). A prospective haemato-oncology patient database. Structure and description. Bone Marrow Transplant., 17 (SuppI 1), S140.
17. Powles, R., Milan, S., Horton, C., Singhal, S., Treleaven, J. and Mehta, J. (1996). A prospective haemato-oncology patient database for use in routine care and clinical research. Bone Marrow Transplant., 17 (Suppl 1), S55.
18. Mehta, J., Powles, R., Treleaven, J. et al. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine, Bone Marrow Transplant (Accepted for publication)
19. Mehta, J., Powles, R., Treleaven, J. et al. (1994). Melphalan versus cyclophosphamide with total body irradiation as conditioning r allogeneic bone marrow transplantation in first remission acute myeloid leukemia, Blood. 84 (Suppl 1), 714a,
20. Barrett, A., Depledge, M. H., Biol, M. and Powles, R. L. (1983). Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation, Int. J. Rad. Oncol. Biol. Phys., 9, 1029-1023.
21. Weiner, R. S., Bortin, M. M., Gale, R. P. et al. (1986). Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors, Ann. Intern. Med., 104, 168-175.
22. Sutton, L., Kuentz, M., Cordonnier, C. et al. (1993). Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities, Bone Marrow Transplant., 12, 583-589.
23. Mehta, J., Powles, R., Singhal, S., Horton, C., Tait, D. and Treleaven, J. (1996). Melphalan-total body irradiation and allogeneic bone marrow transplantation for acute myeloid leukemia in first remission. Bone Marrow Transplant., 17 (Suppl 1), S22.
24. Mehta, J., Powles, R., Singhal, S., Tait, D., Swansbury, J. and Treleaven, J. (1995). Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation, Bone Marrow Transplant., 16, 133-137.
25. Mehta, J., Powles, R., Singhal, S. et al. (1995). Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors, Bone Marrow Transplant., 16, 499-506.